Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,637.18
(
-0.67%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
109.67
(
2.89%
)
Bitcoin
69,651.09
(
-2.23%
)
News Focus
News Focus

Replies to post #16037 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #16037 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

10/28/16 6:21 AM

#16038 RE: biotech_researcher #16037

Positive for MNTA, IMO. Let AMGN deal with the litigation of ABBV's Humira patents (#msg-118781959). By the time MNTA's Humira FoB is approved for marketing, the IP situation may well be clarified.